|
業務類別
|
-- |
|
業務概覽
|
Nanosonics is largely a single-product firm, and its Trophon device provides high-level disinfection of ultrasound probes used in semicritical procedures. The patented technology uses low-temperature sonically activated hydrogen peroxide mist suitable for probes sensitive to damage. Automated HLD is increasingly being used as the standard of care globally as it is superior in preventing cross-infection of patients. Nanosonics' revenue consists of capital sales of Trophon units, ongoing consumables sales, and service revenue. By December 2025, there were 38,000 Trophon units installed globally. Market penetration rates range from over 75% in Australia and New Zealand, over 50% in the US to single-digit penetration in Europe, Middle East, and Africa, and elsewhere in the Asia-Pacific region. |
| 公司地址
| 7-11 Talavera Road, Level 1 Building A, Macquarie Park, Sydney, NSW, AUS, 2113 |
| 電話號碼
| +61 280631600 |
| 傳真號碼
| +61 293175010 |
| 公司網頁
| https://www.nanosonics.com.au |
| 員工數量
| 470 |
| Mr. Michael Kavanagh |
Director, President, Managing Director and Chief Executive Officer |
-- |
26/08/2025 |
|
|
| Ms. Marie McDonald |
Independent Director |
26/08/2025 |
| Dr. Tracey Batten, M.B.A.,M.B.B.S.,M.H.A |
Independent Director |
26/08/2025 |
| Mr. Michael Kavanagh |
Director, President, Managing Director and Chief Executive Officer |
26/08/2025 |
| Dr. Lisa M. McIntyre |
Independent Director |
26/08/2025 |
| Mr. Larry Marshall |
Independent Director |
26/08/2025 |
| Mr. Steven Sargent |
Chairman of the Board |
26/08/2025 |
| Mr. Gerard Dalbosco, B.Com,F.C.A. |
Independent Director |
26/08/2025 |
|
|
|
|
